Nightingale Health Oyj has developed a biomarker profiling technology widely used in population health research. Nightingale has measured biomarkers from ~40,000 samples from THL biobank cohorts. The aim is to use these existing NMR biomarker data for precision medicine research in combination with similar data on >700,000 people in UK and Estonian Biobanks. The research will also help further developments of this technology in healthcare settings.
